猪红斑丹毒丝菌四种表面蛋白保护效力评价
该研究评估了猪红斑丹毒丝菌的GAPDH、HP0728、HP1472和CbpB-N四种表面蛋白作为疫苗候选抗原的保护效力。小鼠模型中重组GAPDH提供完全保护,CbpB-N部分保护,HP0728和HP1472无保护;重组GAPDH在猪模型中也提供良好保护。GAPDH抗血清具有显著杀菌活性,提示GAPDH是有前景的疫苗候选。
要点
- 重组GAPDH在小鼠模型中提供完全保护,在猪模型中提供良好保护。
- 重组CbpB-N提供部分保护,而HP0728和HP1472不提供保护。
- GAPDH抗血清对猪红斑丹毒丝菌具有显著杀菌活性。
核心结论
- GAPDH和CbpB-N是猪红斑丹毒丝菌的保护性抗原,GAPDH是有前景的疫苗候选。
研究设计与样本
- 研究评估了重组GAPDH、HP0728、HP1472和CbpB-N在鼠模型和猪模型中的免疫保护效力。
主要发现
- 小鼠模型中,重组GAPDH免疫提供完全保护,重组CbpB-N提供部分保护。
- 重组HP0728和HP1472免疫不提供保护。
- 重组GAPDH在猪模型中也提供良好保护。
- GAPDH抗血清表现出显著的血液杀菌活性。
临床怎么用
- GAPDH可作为猪红斑丹毒丝菌疫苗开发的候选抗原。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Erysipelothrix rhusiopathiae is the causative agent of animal erysipelas and human erysipeloid. Bacterial surface proteins are promising vaccine candidates. We recently identified 3 E. rhusiopathiae surface proteins (GAPDH, HP0728, and HP1472) and characterized their roles as virulence factors. However, their efficacy as protective antigens is still unknown. The N-terminal region of a previously identified surface protein, CbpB (CbpB-N), is speculated to be a protective antigen, but this needs to be verified. The aim of this study was to evaluate the protective efficacy of GAPDH, HP0728, HP1472, and CbpB-N. Immunization with recombinant GAPDH provided complete protection in a mouse model, recombinant CbpB-N provided partial protection, while recombinant HP0728 and HP1472 provided no protection. Recombinant GAPDH also provided good protection in a pig model. GAPDH antiserum exhibited significant blood bactericidal activity against E. rhusiopathiae. In conclusion, GAPDH and CbpB-N were found to be protective antigens of E. rhusiopathiae, and GAPDH is a promising vaccine candidate.
引用
- Zhu W, Wu C, Kang C, et al. Evaluation of the protective efficacy of four newly identified surface proteins of Erysipelothrix rhusiopathiae. Vaccine. 2018. PMID: 30446176. doi:10.1016/j.vaccine.2018.10.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。